Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor
Yiran Zhang,Hongzhi Hu,Xiangtian Deng,Qingcheng Song,Xin Xing,Weijian Liu,Yingze Zhang
DOI: https://doi.org/10.2147/IJN.S382750
IF: 7.033
2022-11-22
International Journal of Nanomedicine
Abstract:Yiran Zhang, 1– 4, &ast Hongzhi Hu, 5, &ast Xiangtian Deng, 6, &ast Qingcheng Song, 2 Xin Xing, 2, 3 Weijian Liu, 5 Yingze Zhang 1– 3 1 School of Medicine, Nankai University, Tianjin, 300071, People's Republic of China; 2 Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China; 3 NHC Key Laboratory of Intelligent Orthopaedic Equipment, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 4 HeBei Ex&Invivo Biotechnology Co. Ltd, Shijiazhuang, Hebei, 050051, People's Republic of China; 5 Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China; 6 Orthopaedics Research Institute, Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingze Zhang; Weijian Liu, Email ; Background: Although chemodynamic therapy (CDT) has attracted enormous attention in anti-tumor studies for converting endogenous hydrogen peroxide (H 2 O 2 ) into toxic hydroxyl radicals (•OH) by Fenton-type reaction, the treating effects of using CDT alone is still unsatisfying. Recently, glucose oxidase (GOx) was reported to be co-delivered with Fenton agent for synergistic starvation therapy (ST) and CDT. However, the overexpressed glutathione (GSH) and hypoxia in tumor microenvironment (TME) restrict the therapeutic efficacy of ST/CDT. Methods and Results: In this work, a novel nanoplatform composed of GOx plus Fenton agent (Cu 2+ ) encapsulated core and metformin (MET)-loaded manganese dioxide nanosheets (MNSs) shell was prepared and further functionalized by arginine-glycine-aspartate (RGD). With the RGD-mediated affinity with cancer cells, the nanocomposite (@PEG-RGD, GCMMR) could accomplish targeting delivery and TME-activated release of cargos. The intracellular GSH was depleted by MnO 2 /Cu 2+ and abundant H 2 O 2 was generated along with the GOx-induced glucose deprivation, which process was further enhanced by MET-mediated hypoxia relief via inhibiting mitochondria-associated respiration. Subsequently generated •OH from Cu + -mediated Fenton-like reaction exerts severe intracellular oxidative stress and cause apoptosis. Moreover, significant inhibition of tumor growth was detected in a subcutaneous xenograft model of osteosarcoma (OS) after GCMMR treatment. Conclusion: The excellent therapeutic efficacy and biosafety of the nanoplatform were confirmed both in vitro and in vivo. Collectively, this study provides an appealing strategy with catalytic cascade enhancement on targeted ST/CDT for cancer treatment, especially for hypoxic solid tumors. Graphical Keywords: chemodynamic therapy, starvation therapy, glucose oxidase, Fenton reaction, biomineralization, metformin Graphical Among numerous reactive oxygen species (ROS)-based anticancer strategies, chemodynamic therapy (CDT) is attracting particular attention. 1,2 This nanocatalytic modality selectively converts endogenous hydrogen peroxide (H 2 O 2 ) in tumor microenvironment (TME) to cytotoxic hydroxyl radicals (•OH) through Fenton-type reaction thus avoiding damage to normal tissues. 3 However, the relative insufficiency of H 2 O 2 and overexpressed intracellular glutathione (GSH) in TME restrict the anticancer effect of CDT. 4–6 Glucose oxidase (GOx), as a natural catalyst, can convert glucose into gluconic acid and generate H 2 O 2 within tumor cells. 7,8 Thus, GOx was recently explored to be co-delivered with Fenton/Fenton-like agents to realize cascade catalysis. 9–11 Moreover, the glucose-consuming feature of GOx can perturb energy metabolism in tumor cells, fulfilling synergistic starvation therapy (ST). 12 Nevertheless, this GOx-mediated catalytic process is O 2 -reliant and would be limited by hypoxic microenvironment in solid tumors. 13 In this regard, to improve the cascade catalytic effect of starving-chmodynamic therapy, this hypoxia-associated obstacle must be conquered. Previous studies showed the hypoxia of tumor cells was mainly due to the over-consumption of oxygen during the oxidative phosphorylation in mitochondria, along with which adenosine triphosphate (ATP) was produced. 14,15 Thus, interfering with the p -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology